<DOC>
	<DOCNO>NCT00903578</DOCNO>
	<brief_summary>The present study examine whether serum FGF-23 serum phosphate baseline kidney transplant recipient predict progression allograft dysfunction 3 year all-cause mortality 5 year .</brief_summary>
	<brief_title>Impact Fibroblast Growth Factor 23 ( FGF-23 ) Serum Phosphate Allograft Function Mortality Kidney Allograft Recipients</brief_title>
	<detailed_description />
	<criteria>least one year posttransplantation 10 % increase serum creatinine past 3 month refuse participate study acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>FGF-23</keyword>
	<keyword>vitamin D</keyword>
	<keyword>phosphate</keyword>
	<keyword>allograft dysfunction</keyword>
	<keyword>mortality</keyword>
</DOC>